±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1237  |  »Ø¸´: 3
¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß ivers12 µÄ 9 ¸ö½ð±Ò

ivers12

Ìú¸Ëľ³æ (СÓÐÃûÆø)

[½»Á÷] »ùÒò¶¾ÐÔÔÓÖÊÑо¿

Çë½ÌÒ»¸öÎÊÌ⣺
Èç¹ûÒ©µäÖеÄij¸öÒÑÖªÔÓÖÊ£¬º¬ÓкÍAPI²»Í¬µÄ¾¯Ê¾½á¹¹£¬ÊÇ·ñÐèÒª°´ÕÕ»ùÒò¶¾ÐÔÔÓÖÊÑо¿£¨ÕâÀïÔݲ»ÌÖÂÛÊÇ·ñÐèÒªÈí¼þÔ¤²â£¬Ö»¿´¾¯Ê¾½á¹¹£©
·ÖΪÁ½ÖÖÇé¿ö£º
1¡¢Ò©µäÖÐÃ÷È·¸ÃÔÓÖʵÄÏÞ¶È
2¡¢Ò©µäÖÐδÃ÷È·¸ÃÔÓÖʵľßÌåÏÞ¶È
Ó¦¸ÃÈçºÎ´¦ÀíÄØ£¿
»Ø¸´´ËÂ¥
ÉϺ£
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Alian2013

Í­³æ (³õÈëÎÄ̳)

¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ivers12: ½ð±Ò+1 2022-01-24 13:18:10
ÔÓÖÊ»¹ÓкÍAPI²»Í¬µÄ»ùÒò¶¾¾¯Ê¾½á¹¹£¬Ó¦¸Ã°´M7ÖеĵÚÈýÖÖÇé¿ö½øÐлùÒò¶¾Ñо¿£¬ÈçÈôICH¸ø³öÔÓÖÊÏÞ¶È£¬¿É°´ÕÕ¸ø³öµÄÏÞ¶ÈÑо¿£¬ÈçÈôûÓиø³öÔÓÖÊÏÞ¶È£¬¿ÉÒÔ¸ù¾ÝICH¸ø³öµÄʹÓÃʱ¼äÖÜÆÚ¶ÔÓ¦µÄPDEºÍ×î´óÓÃÒ©Á¿¼ÆË㣬Ҳ¿ÉÒÔ°´ÕÕ1.5ug/ÌìµÄPDEÓÃÒ©Ñо¿£¬·çÏÕ×îµÍ¡£
ºÚÒ¹¸øÁËÎÒºÚÉ«µÄÑÛ¾¦£¬ÎÒÈ´ÓÃËüÀ´Ñ°ÕÒ¹âÃ÷£¡
2Â¥2022-01-18 15:36:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ivers12

Ìú¸Ëľ³æ (СÓÐÃûÆø)

±ÈÈçÕâ¸öBPÖеģº
Limits:

¡ª impurity A: maximum 0.2 per cent;
¡ª impurity F: maximum 0.15 per cent;
¡ª unspecified impurities: for each impurity, maximum 0.10 per cent;
¡ª total: maximum 0.4 per cent;
¡ª reporting threshold: 0.05 per cent.

Specified impurities A, F.

Other detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other/unspecified impurities and/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use) B, C, D, E.

ÕâÖÖÇé¿öÏ£¬ÔÓÖÊA£¬ÔÓÖÊF£¬ºÍÔÓÖÊB£¨º¬¾¯Ê¾½á¹¹£©µÄÏÞ¶ÈÈçºÎ½ç¶¨£¿
ÉϺ£
3Â¥2022-01-27 13:32:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mrzhl1986

½ð³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ºÜÃ÷È·Á˰¡¡£¼ÈÈ»ÊÇÒ©µä¸ø³öµÄÔÓÖÊÈç¹û²»ÔÚµ¥¶À¿ØÖƵÄÔÓÖÊÖÐÄǾÍÊôÓÚÆäËüµ¥ÔÓÁË£¬°´ÕÕÆäËüµ¥ÔӿؾÍÐÐÁË¡£
Ëûʲô¶¼Ã»ÁôÏÂ
4Â¥2022-02-08 17:38:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ivers12 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +9 ÀÁÑòÑòÇáÖÃÓñÍÎ 2026-04-02 9/450 2026-04-04 19:14 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 359Çóµ÷¼Á +7 hhhhaaaa$ 2026-04-04 7/350 2026-04-04 18:49 by imissbao
[¿¼ÑÐ] 288»·¾³×¨Ë¶,Çóµ÷²ÄÁÏ·½Ïò +3 lllllos 2026-04-04 3/150 2026-04-04 18:34 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 321Çóµ÷¼Á +13 ÈÏÕæÇóÉÏѧ 2026-04-02 13/650 2026-04-04 18:23 by macy2011
[¿¼ÑÐ] 285Çóµ÷¼Á +4 AZMK 2026-04-04 5/250 2026-04-04 16:45 by cql1109
[¿¼ÑÐ] 0856Çóµ÷¼Á +11 —öèñ 2026-03-28 11/550 2026-04-04 16:18 by dongzh2009
[¿¼ÑÐ] 317·Ö Ò»Ö¾Ô¸½­ÄÏ´óѧ »¯Ñ§¹¤³Ìѧ˶ Çóµ÷¼Á +6 YinTai 2026-04-03 6/300 2026-04-03 22:30 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 070300Ò»Ö¾Ô¸211£¬312·ÖÇóµ÷¼ÁԺУ +16 С»ÆÑ¼±¦ 2026-03-30 16/800 2026-04-03 19:53 by lijunpoly
[¿¼ÑÐ] 301Çóµ÷¼Á +14 A_JiXing 2026-04-01 14/700 2026-04-03 18:31 by lsÁõ˧
[¿¼ÑÐ] 11408 359·Ö Çóµ÷¼Á +4 yfever 2026-03-28 4/200 2026-04-03 16:43 by asdfzly
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉúÎïÓëÒ½Ò©£¬296·Ö£¬Çóµ÷¼Á +8 66¹ 2026-04-03 9/450 2026-04-03 14:22 by »¯Ñ§»¯¹¤Ë¶Ê¿ÕÐÉ
[¿¼ÑÐ] 296²ÄÁÏר˶Çóµ÷¼Á +20 202451007219 2026-04-02 21/1050 2026-04-03 11:15 by wangjy2002
[¿¼ÑÐ] 302Çóµ÷¼ÁÒ»Ö¾Ô¸»ªÖÐʦ·¶´óѧ +7 С½­Ð¡½­½­½­ 2026-04-02 7/350 2026-04-02 21:48 by macy2011
[¿¼ÑÐ] ³õÊÔ301£¬´úÂë085701»·¾³¹¤³Ì£¬±¾Ë¶Ò»Ö£¬ËÄÁù¼¶Òѹý£¬ÓжþÇøÒ»×÷£¬¹²·¢±í5ƪÂÛÎÄ +6 axibli 2026-04-01 6/300 2026-04-02 13:42 by Ecowxq666£¡
[¿¼ÑÐ] 302Çóµ÷¼ÁÒ»Ö¾Ô¸±±º½070300£¬±¾¿ÆÖ£´ó»¯Ñ§ +8 Ê¥ÈÕ¶úÂüÌõ 2026-04-01 11/550 2026-04-02 07:40 by chemdavid
[¿¼ÑÐ] 298Çóµ÷¼Á +4 ʲôÊÇÅÖÍ·Óã 2026-03-30 6/300 2026-04-01 22:06 by ¿Í¶ûÃÀµÂ
[¿¼ÑÐ] Çóµ÷¼Á +4 ͼ¼ø212 2026-03-30 5/250 2026-04-01 15:32 by ͼ¼ø212
[¿¼ÑÐ] 267Çóµ÷¼Á +13 uiybh 2026-03-31 13/650 2026-04-01 10:25 by ̽123
[¿¼ÑÐ] µ÷¼ÁÉêÇë +8 ÕÅÕÅÕÅÕÅzy 2026-03-31 9/450 2026-04-01 08:29 by zjbkx
[¿¼ÑÐ] 266Çóµ÷¼Á +3 ÍÛºôºßºôºß 2026-03-29 3/150 2026-03-31 10:06 by cal0306
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û